Please check your internet connection and try again.
# D-Cold
## Overview
D-Cold is a combination product containing **Dextromethorphan** (a cough suppressant) and **Chlorpheniramine** (an antihistamine). The specific formulation requested, "D%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cold," is not a recognized standard drug name. It is assumed this refers to a common over-the-counter (OTC) cold preparation containing these active ingredients. Actual product composition and available strengths may vary significantly.
## Primary Indications
* Symptomatic relief of cough and common cold symptoms, including runny nose and sneezing.
## Adult Dosing
Dosing for OTC combination products varies by manufacturer and specific formulation. A typical adult dose for products containing **Dextromethorphan 10 mg** and **Chlorpheniramine 4 mg** is:
* 1-2 tablets or 10-20 mL every 4-6 hours as needed.
* **Maximum Dextromethorphan:** Typically 120 mg per 24 hours.
* **Maximum Chlorpheniramine:** Typically 24 mg per 24 hours.
**Note:** Dosing must be based on the specific product labeling.
## Pediatric Dosing
Dosing for pediatric patients is highly dependent on the specific product formulation and age. Many combination products are **not recommended for children under 6 years of age** due to the risk of serious adverse effects.
* **Children 6-12 years:** Follow product labeling, typically half the adult dose.
* **Children under 6 years:** **Not recommended** without physician guidance.
**Note:** Always consult the product's specific dosing instructions for children.
## Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustments are established for OTC formulations. Caution is advised due to potential accumulation, especially with Chlorpheniramine.
* **Renal Impairment:** No specific dose adjustments are established for OTC formulations. Caution is advised.
## Contraindications
* Hypersensitivity to Dextromethorphan or Chlorpheniramine.
* Use within 14 days of MAOI therapy (for Dextromethorphan, risk of serotonin syndrome).
* Narrow-angle glaucoma (for Chlorpheniramine).
* Acute asthma exacerbation.
* Stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, bladder neck obstruction (for Chlorpheniramine).
* Newborn or premature infants (for Chlorpheniramine).
## Adverse Effects
* **Dextromethorphan:** Dizziness, drowsiness, nausea, vomiting, confusion, hallucinations (at higher doses).
* **Chlorpheniramine:** Sedation, dizziness, dry mouth, blurred vision, urinary retention, constipation. Paradoxical excitation in children.
## Key Drug Interactions
* **MAO Inhibitors:** Increased risk of serotonin syndrome with Dextromethorphan.
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids):** Additive sedative effects.
* **Anticholinergic agents:** Increased risk of anticholinergic side effects with Chlorpheniramine.
* **CYP2D6 Inhibitors:** Increased plasma concentrations of Dextromethorphan, potentially leading to toxicity.
## Monitoring
* Monitor for effectiveness in symptom relief.
* Assess for adverse effects, particularly sedation, confusion, and anticholinergic effects.
* Monitor for signs of serotonin syndrome if concomitant serotonergic agents are used.
## Clinical Pearls
* Dextromethorphan is a cough suppressant, and Chlorpheniramine is an antihistamine for cold symptoms.
* Many OTC products combine these ingredients; always verify the exact strength and dosage on the product label.
* Drowsiness is a common side effect; avoid driving or operating heavy machinery.
* Due to potential for misuse and abuse, Dextromethorphan is a controlled substance in some jurisdictions.
* Ensure adequate hydration when using cough suppressants.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace current prescribing information. Always consult the official product labeling and relevant drug references for the most up-to-date and comprehensive details before making clinical decisions.
